can i switch from mounjaro to retatrutide vs UK Retatrutide vs Mounjaro: Which is

GLP-1 receptor agonistswhich are currently FDA-approved for people who are obese (a BMI of 30 or greater), have type 2 diabetes, or are overweight (a BMI of at least 27) and have cardiovascular disease or other risk factorsare emerging as a promising non-hormonal option for cardiometabolic protection during menopause

When you consume fewer calories than you burn, your body needs to tap into energy stores to make up the difference

Do not freeze it, as the freeze-thaw cycle can degrade the peptide

This selectivity makes it distinct in metabolic research

And that's totally understandable - it's a personal decision that you'll need to make with your healthcare team